The Effect of Myopic Optical Defocus on the Humphrey Matrix 30-2 Test
NCT ID: NCT00638430
Last Updated: 2008-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2007-03-31
2008-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of the present study is twofold. At first, the influence of the low-grade myopia on the Humphery Matrix 30-2 test will be evaluated and compared to the effect of moderate-grade myopia. Secondly, the influence of myopic optical defocus and the glaucomatous visual field damage on the pattern deviation plot change according to the severity of glaucomatous visual field damage will be estimated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
low myopic group
No interventions assigned to this group
2
moderate myopic group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* suspicious glaucomatous optic disc change
* suspicious defect of retinal nerve fiber layer
* or eyes with various degrees of glaucoma
Exclusion Criteria
* moderate to severe cataract
* evidence of diabetic or hypertensive retinopathy
* macular disease
* intra-ocular inflammation
* history of intraocular surgery and any other ocular lesion that could have an influence on the perimetry result
27 Years
61 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Ophthalmology, Samsung Medical Center,
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Changwon Kee, M.D.
Role: STUDY_CHAIR
Department of Ophthalmology, Samsung Medical Center,
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Anderson AJ, Johnson CA. Frequency-doubling technology perimetry and optical defocus. Invest Ophthalmol Vis Sci. 2003 Sep;44(9):4147-52. doi: 10.1167/iovs.02-1076.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Humphrey30-2
Identifier Type: -
Identifier Source: org_study_id